Yasuhiro Tsume

The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC

Yasuhiro Tsume, Deanna M. Mudie, Peter Langguth et al. · European Journal of Pharmaceutical Sciences · 2014 · 323 citations · Full text

Medicine, Drug Discovery, Bioanalysis +8

The Suitability of an in Situ Perfusion Model for Permeability Determinations:  Utility for BCS Class I Biowaiver Requests

Jae-Seung Kim, Stefanie Mitchell, Paul Kijek et al. · Molecular Pharmaceutics · 2006 · 157 citations

Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells

Joseph Burnett, Gi Lim, Yanyan Li et al. · Cancer Letters · 2017 · 150 citations · Full text

Oncology, Medicine, Anticancer Activity +8

Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for <i>in Vivo</i> Dissolution and Absorption of Ionizable Drugs

Bart Hens, Yasuhiro Tsume, Marival Bermejo et al. · Molecular Pharmaceutics · 2017 · 125 citations

Ibuprofen Tablet, Healthy Subjects, Gastrointestinal Pharmacology +22

<i>In silico</i> prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen

Yasuhiro Tsume, Peter Langguth, Alfredo García‐Arieta et al. · Biopharmaceutics & Drug Disposition · 2012 · 104 citations · Full text